Story
Candel Therapeutics Stock Jumps on BofA Securities Upgrade to 'Buy'
Summary
Shares of Candel Therapeutics (CADL) surged in pre-market trading after BofA Securities upgraded the stock to 'Buy' from 'Neutral' and raised its price target to $18, citing upcoming catalysts.
Shares of Candel Therapeutics Inc. (NASDAQ: CADL) jumped on Monday after BofA Securities upgraded the biotechnology company to 'Buy' from a previous 'Neutral' rating. The positive revision sent the company's stock up 9.3% in pre-market trading.
Upgrade Details
BofA Securities analyst Alec Stranahan raised the firm's price target on Candel Therapeutics to $18.00 per share, a significant increase from the previous target of $12.00. The upgrade reflects a more optimistic outlook on the company's prospects.
This change was part of a broader H2 2026 outlook report on the biotechnology sector released by the investment bank. For investors, such a substantial upgrade and price target hike from a major firm like BofA can signal increased confidence in a company's future performance and pipeline.
AdAnalyst Rationale
In the research note, Stranahan specifically highlighted Candel Therapeutics among several stocks being re-rated due to potential near-term events. The analyst pointed to key regulatory developments and data catalysts as primary drivers for the more favorable view.
The note also conveyed a bullish stance on the biotech sector as a whole for 2026. Stranahan emphasized that the sector is poised to be a top performer, with 'continued improvement in participation from various investor groups' expected to provide additional upward momentum.
Read next
More on Stocks
Citi Projects 53% Surge in AI-Driven Enterprise SSD Demand by 2027, Recommends Samsung and SK Hynix
A new Citi report forecasts that artificial intelligence will drive a 52.9% year-over-year increase in enterprise solid-state drive (eSSD) demand in 2027, creating a significant supply deficit and benefiting key memory chip manufacturers.
S&P Cuts Telus Outlook to Stable on Weaker Guidance, Higher Leverage Forecast
S&P Global Ratings has revised its outlook on Telus Corp. to 'Stable' from 'Positive,' citing the company's weaker financial guidance which is expected to result in higher leverage. The rating agency affirmed the telecom's 'BBB-' credit rating.
Falling Oil Prices Lift Airline and Cruise Line Shares
Major U.S. airline and cruise line stocks gained in pre-market trading Monday as crude oil prices fell to an 11-day low on hopes for easing geopolitical tensions. The decline in fuel costs, a major operating expense, provided a boost to the travel sector.
Raymond James Names Allison, Griffon, and Construction Partners as Top Industrial Picks
Investment firm Raymond James has updated its "Analyst Current Favorites" list, highlighting three industrial sector stocks—Allison Transmission, Griffon Corp., and Construction Partners—as its top investment ideas based on strong fundamentals and upcoming catalysts.